Aspirin May Lower Risk of HBV-Related Hepatocellular Carcinoma
Patients who take aspirin may significantly reduce their risk of hepatitis B-related hepatocellular carcinoma.
Patients who take aspirin may significantly reduce their risk of hepatitis B-related hepatocellular carcinoma.
Human papillomavirus vaccine initiation rates are low among young cancer survivors.
HIV infection may not contribute to incidence of invasive cervical cancer.